According to the enterprise research app, recently, Xiamen Construction Life Technology Industry Co., Ltd. was established. The legal representative is Cheng Dongfang, with a registered capital of 1 billion yuan. The business scope includes medical research and experimental development; cell technology research and development; human stem cell technology development and application; and bio-based material technology research and development. Enterprise investigation and equity penetration shows that the company is jointly owned by Xiamen C&D Group Co., Ltd. and Xiamen C&D Emerging Industries Equity Investment Co., Ltd.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.